TherapeuticsMD (TXMD) EBITDA Margin (2011 - 2026)
TherapeuticsMD's EBITDA Margin came in at -82.97% for Q2 2026, down 20.05 percentage points from -62.92% a year earlier but up 3.91 percentage points from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) EBITDA Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, TherapeuticsMD reported EBITDA Margin of -109.20%, up 22.68 percentage points year-over-year; for FY2025, it was -132.56%, up 185.61 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +100.52 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -318.17% in FY2024 (+265.62 pp), -583.79% in FY2023 (-587.20 pp), 3.41% in FY2022 (+3067.57 pp) and -3064.17% in FY2021 (-2831.09 pp).
- The five-year range for quarterly EBITDA Margin is -4188.22% (Q2 2022) to 71.10% (Q4 2022).
- Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +537.61 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2023 (a gain of 3652.06 percentage points), and the weakest in Q2 2022 (a drop of 4039.80 percentage points).
- Business Quant data shows TXMD's EBITDA Margin at -86.88% (Q1 2026), -162.93% (Q4 2025) and -97.70% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | -82.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -82.97% |
| Mar 31, 2026 | -86.88% |
| Dec 31, 2025 | -162.93% |
| Sep 30, 2025 | -97.70% |
| Jun 30, 2025 | -62.92% |
| Mar 31, 2025 | -301.78% |
| Dec 31, 2024 | -82.76% |
| Sep 30, 2024 | -189.76% |
| Jun 30, 2024 | -1,114.96% |
| Mar 31, 2024 | -322.36% |
| Dec 31, 2023 | -194.02% |
| Sep 30, 2023 | -3,100.00% |
| Jun 30, 2023 | -536.16% |
| Mar 31, 2023 | -634.62% |
| Dec 31, 2022 | 71.10% |
| Sep 30, 2022 | -4,024.29% |
| Jun 30, 2022 | -4,188.22% |
| Mar 31, 2022 | -2,524.60% |
| Dec 31, 2021 | -202.09% |
| Sep 30, 2021 | -153.08% |
API Access
TherapeuticsMD EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();